Soleno Therapeutics(US:SLNO) Benzingaยท2025-09-10 18:01Group 1 - Deep-pocketed investors have adopted a bearish approach towards Soleno Therapeutics, indicating that significant market movements may be imminent [1][2] - Among heavyweight investors, 32% are bullish while 51% are bearish, with notable options activity including 8 puts totaling $504,980 and 23 calls amounting to $1,156,660 [2] - The projected price targets for Soleno Therapeutics are between $55.0 and $70.0, based on the analysis of volume and open interest in options contracts [3] Group 2 - The average open interest for Soleno Therapeutics options is 476.88, with total volume reaching 23,916.00, indicating heightened trading activity [4] - Recent options activity includes various trades with significant total trade prices, such as a bullish put trade for $164.4K and a bearish call trade for $136.4K [9] - Soleno Therapeutics is currently trading at $61.83, down by -11.94%, with a trading volume of 5,714,276 [15] Group 3 - Soleno Therapeutics is a biopharmaceutical company focused on developing novel therapeutics for rare diseases, with its product candidate DCCR showing promise in activating KATP channels [11] - Professional analysts have set an average price target of $113.0 for Soleno Therapeutics, with varying ratings from different firms [12][13]